Ambalal Sarabhai Enterprises Limited (NSE:AMBALALSA)

Market Cap	2.53B -9.9%
Revenue (ttm)	2.17B +10.2%
Net Income	178.04M +261.0%
EPS	2.32 +262.5%
Shares Out	n/a
PE Ratio	14.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,874
Average Volume	85,478
Open	33.60
Previous Close	32.75
Day's Range	32.60 - 34.50
52-Week Range	30.30 - 36.15
Beta	n/a
RSI	51.85
Earnings Date	May 21, 2026

About NSE:AMBALALSA

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, markets, and supplies pharmaceutical products in India and internationally. The company offers products for oncology, infertility, and uro-gynaec areas; generic and veterinary products; antifungal active ingredient products; vitamin C coated products; and analytical, test, and measuring instruments, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides broadcast and professional video/audio, and electronic products. Am...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 104
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMBALALSA

Financial Performance

In fiscal year 2026, NSE:AMBALALSA's revenue was 2.17 billion, an increase of 10.19% compared to the previous year's 1.97 billion. Earnings were 178.04 million, an increase of 261.05%.